2012
Annual Report to the Community
and Report on Philanthropy
2012
Annual Report to the Community
and Report on Philanthropy
Marc Diamond, MD
Washington University
Alzheimer’s disease: Testing antibodies to create more effective methods for predicting the onset, and treating the progression, of Alzheimer’s and other neurodegenerative diseases.
Roger Greenberg, MD, PhD
University of Pennsylvania
Cancer: Developing a promising approach for chemotherapy to treat breast and ovarian cancer, based on targeting DNA pathways to repair dysfunctional cancer cells.
Geoffrey Gurtner, MD, FACS
Stanford University
Wound healing: Developing a medicated transdermal patch to enhance blood vessel formation and reduce potential complications of wound healing in diabetic patients.
Richard Kitsis, MD
Einstein College of Medicine
Myocardial infarction: Studying the mechanisms of cell death and creating a first-in-class drug to delay cardiac muscle damage during a heart attack.
Wolfgang Liedtke, MD, PhD
Duke University
Pain control: Developing a new class of drugs that inhibit the pain response in skin, with potential applications in many conditions including sunburn and wound pain.
Sanford Markowitz, MD, PhD
Case Western Reserve University
Pulmonary hypertension and liver regeneration: Developing compounds that treat pulmonary artery hypertension, accelerate recovery after bone marrow transplants and regenerate liver tissue following injury.
Scott Oakes, MD
University of California, San Francisco
ALS (Lou Gehrig’s disease) and multiple myeloma: Studying molecular events that control cell behavior and designing medications to protect against cell death in ALS, multiple myeloma and diabetes.
Jonathan Powell, MD, PhD
The Johns Hopkins University
Diabetes: Developing a new class of drugs for treating type 2 diabetes, obesity and high blood cholesterol.
Larry Schlesinger, MD
The Ohio State University
Tuberculosis: Studying a new pathway in bacteria that translates into medications for treating tuberculosis.
Robert Wilson, MD, PhD
University of Pennsylvania
Cancer: Identifying a new approach to treat all forms of cancer.